Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05131035 · ClinicalTrials.gov registry record · NA

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk

A NA study of Psychosis and Prodromal Schizophrenia, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
54
Enrollment target
1
Study location

NCT05131035 is a NA study of Psychosis and Prodromal Schizophrenia that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 54 participants, below the 177-participant average among 35 other Psychosis trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05131035, a NA study of Psychosis and Prodromal Schizophrenia, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, represents a vulnerability factor for psychosis. This remotely-delivered intervention combining targeted cognitive training exercises and group support was developed to directly impact processing speed, and at the same time, boost motivation and engagement in adolescents at risk for schizophrenia and other psychotic disorders.

Interventions

  • BEHAVIORAL SCORES (Specific COgnitive Remediation with Support)

Study Locations (1)

New York

  • Northwell Health- The Zucker Hillside Hospital - Glen Oaks

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2021-10-28
Est. Completion 2026-05-31
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT05131035

The ClinicalTrials.gov registry entry for NCT05131035 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 35 other Psychosis trials with a reported enrollment target (69% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Psychosis appearing as the primary indexed condition, and to 1 intervention - of which SCORES (Specific COgnitive Remediation with Support) is the first listed.

NCT05131035 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05131035 about?

NCT05131035 is a clinical study titled "Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk". This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, represents a vulnerability factor for psychosis. This remotely-delivered intervention combining targe...

What is the current status of trial NCT05131035?

This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2021-10-28. Estimated completion is 2026-05-31.

What conditions does trial NCT05131035 study?

This clinical trial studies the following conditions: Psychosis, Prodromal Schizophrenia, Prodromal Symptoms.

What interventions are being tested in trial NCT05131035?

The interventions under investigation include: SCORES (Specific COgnitive Remediation with Support) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05131035?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05131035 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.